Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nipped-B-like protein (NIPBL) is a chromosomal protein required for loading the cohesin complex onto chromatin, ensuring sister chromatid cohesion and proper chromosome segregation during cell division[1][2][3][4][7]. NIPBL forms a complex with MAU2/SCC4, collectively termed the cohesin loading complex, which is essential for cohesin’s association with DNA[2][3][4][7]. Besides its key role in cell division, NIPBL participates in DNA repair, regulation of gene expression, RNA biogenesis, and possibly in developmental signaling pathways (including Wnt signaling)[8][4]. Mutations in the NIPBL gene are the main cause of Cornelia de Lange syndrome, a multisystem developmental disorder characterized by distinctive facial features, growth delay, limb abnormalities, and cognitive disabilities[1][3][4]. NIPBL’s centrality in genome stability, regulation, and development makes it a target of research for understanding cohesinopathies and exploring implications in cancer and regenerative medicine, though no drugs currently target NIPBL directly for therapy[3][4].
Not applicable; no approved drugs known to target NIPBL directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nipped-B-like protein (NIPBL).